Geneva Partners, LLC Bio Techne Corp Transaction History
Geneva Partners, LLC
- $239 Million
- Q2 2024
Shares
2 transactions
Others Institutions Holding TECH
# of Institutions
604Shares Held
153MCall Options Held
171KPut Options Held
56.9K-
Vanguard Group Inc Valley Forge, PA18.2MShares$1.35 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY15MShares$1.11 Billion0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD8.53MShares$631 Million0.07% of portfolio
-
State Street Corp Boston, MA6.3MShares$466 Million0.02% of portfolio
-
Bamco Inc New York, NY4.78MShares$353 Million1.0% of portfolio
About BIO-TECHNE Corp
- Ticker TECH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,222,600
- Market Cap $2.9B
- Description
- Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...